دورية أكاديمية
Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
| العنوان: | Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy. |
|---|---|
| المؤلفون: | Santo G; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.; Department of Experimental and Clinical Medicine, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy., Di Santo G; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria., Zelger B; Pathology, Medical University of Innsbruck, Innsbruck, Austria., Virgolini I; Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria. |
| المصدر: | Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Jun; Vol. 63 (3), pp. 219-220. Date of Electronic Publication: 2024 Jan 08. |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Thieme Country of Publication: Germany NLM ID: 7609387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-6407 (Electronic) Linking ISSN: 00295566 NLM ISO Abbreviation: Nuklearmedizin Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2018- : Stuttgart : Thieme Original Publication: Stuttgart, F.K. Schattauer. |
| مواضيع طبية MeSH: | Positron Emission Tomography Computed Tomography* , Gallium Radioisotopes* , Gallium Isotopes* , Pancreatic Neoplasms*/diagnostic imaging , Pancreatic Neoplasms*/radiotherapy , Incidental Findings* , Adenocarcinoma*/diagnostic imaging , Adenocarcinoma*/radiotherapy , Lutetium*/therapeutic use, Humans ; Male ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/pathology ; Edetic Acid/analogs & derivatives ; Radiopharmaceuticals/therapeutic use ; Aged ; Oligopeptides ; Prostate-Specific Antigen |
| مستخلص: | Competing Interests: The authors declare that they have no conflict of interest. |
| المشرفين على المادة: | 0 (Gallium Radioisotopes) 0 (Gallium Isotopes) 0 (gallium 68 PSMA-11) 5H0DOZ21UJ (Lutetium) 0 (Dipeptides) 0 (Heterocyclic Compounds, 1-Ring) 9G34HU7RV0 (Edetic Acid) 0 (Pluvicto) 0 (Radiopharmaceuticals) 0 (Oligopeptides) 0 (PSMA-11) EC 3.4.21.77 (Prostate-Specific Antigen) |
| تواريخ الأحداث: | Date Created: 20240108 Date Completed: 20240529 Latest Revision: 20240529 |
| رمز التحديث: | 20240530 |
| DOI: | 10.1055/a-2221-3220 |
| PMID: | 38190993 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2567-6407 |
|---|---|
| DOI: | 10.1055/a-2221-3220 |